JohnQAdamsMD

PubMed

• 3 citations
  Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes
  S Abdelgani, Curtiss Puckett, John Adams, Curtis L Triplitt, Ralph A. DeFronzo, Muhammad A. Abdul-Ghani> ;The Journal of Clinical Endocrinology and Metabolism. 2021 Aug 3
• 2 citations
  Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study
  Siham Abdelgani, Curtiss Puckett, John Adams, Curtis L Triplitt, Ralph A. DeFronzo, Muhammad A. Abdul-Ghani> ;Diabetes, Obesity & Metabolism. 2021 Jul 1
• 21 citations
  Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
  Muhammad A. Abdul-Ghani, Curtiss Puckett, John Adams, Ahmad Khattab, Gozde Baskoy, Eugenio Cersosimo, Curtis L Triplitt, Ralph A. DeFronzo> ;Diabetes Care. 2021 Feb 1
• 10 citations
  Improved Beta Cell Glucose Sensitivity Plays Predominant Role in the Decrease in HbA1c with Cana and Lira in T2DM
  Ali M. Ali, Andrea Mari, Hussein Al-Jobori, John Adams, Curtis L Triplitt, Ralph A. DeFronzo, Eugenio Cersosimo, Muhammad A. Abdul-Ghani> ;The Journal of Clinical Endocrinology and Metabolism. 2020 Oct 1
• Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin
  Yuejuan Qin, John Adams, Carolina Solis-Herrera, Curtis L Triplitt, Ralph A. DeFronzo, Eugenio Cersosimo> ;Diabetes Care. 2020 Jul 21
• 12 citations
  Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion
  Carolina Solis-Herrera, Giuseppe Daniele, Mariam Alatrach, Christina Agyin, Curtis L Triplitt, John Adams, Rupal Patel, Amalia Gastaldelli, Henri Honka, Xi Chen, Muham...> ;Diabetes Care. 2020 May 1
• 16 citations
  Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors.
  Mariam Alatrach, Nitchakarn Laichuthai, Christina Agyin, Ali M. Ali, Hussein Al-Jobori, Olga Lavynenko, John Adams, Curtis L Triplitt, Ralph A. DeFronzo, Eugenio Cerso...> ;Diabetes. 2020 Apr 1
• 25 citations
  Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA1c, in Patients With Type 2 Diabetes.
  Ali M. Ali, Hussein Al-Jobori, John Adams, Curtis L Triplitt, Ralph A. DeFronzo, Eugenio Cersosimo, Muhammad A. Abdul-Ghani> ;Diabetes Care. 2020 Mar 20
• 3 citations
  Exenatide modulates visual cortex responses
  Paola Binda, Roy Eldor, Claudia Huerta, John Adams, Jack L. Lancaster, Peter T. Fox, Stefano Del Prato, Ralph A. DeFronzo, Muhammad A. Abdul-Ghani, Giuseppe Daniele> ;Diabetes/metabolism Research and Reviews. 2019 Sep 1
• 13 citations
  Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG
  Mariam Alatrach, Christina Agyin, Rucha J. Mehta, John Adams, Ralph A. DeFronzo, Muhammad A. Abdul-Ghani> ;The Journal of Clinical Endocrinology and Metabolism. 2019 Jan 1
• 7 citations
  Glucose lowering and vascular protective effects of cycloset added to GLP-1 receptor agonists in patients with type 2 diabetes.
  Mariam Alatrach, Christina Agyin, John Adams, Robert J. Chilton, Curtis L Triplitt, Ralph A. DeFronzo, Eugenio Cersosimo> ;Endocrinology, Diabetes & Metabolism. 2018 Aug 15
• 38 citations
  Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy.
  Hussein Al-Jobori, Ali M. Ali, John Adams, Muhammad A. Abdul-Ghani, Curtis L Triplitt, Ralph A. DeFronzo, Eugenio Cersosimo> ;Diabetes. 2018 Mar 30
• 53 citations
  Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus.
  Hussein Al Jobori, Giuseppe Daniele, John Adams, Eugenio Cersosimo, Carolina Solis-Herrera, Curtis L Triplitt, Ralph A. DeFronzo, Muhammad A. Abdul-Ghani> ;The Journal of Clinical Endocrinology and Metabolism. 2018 Apr 1
• 15 citations
  Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects.
  Roy Eldor, Giuseppe Daniele, Claudia Huerta, Mariam Al-Atrash, John Adams, Ralph A. DeFronzo, Timothy Q. Duong, Jack L. Lancaster, Mahmoud Zirie, Amin Jayyousi, Muhamm...> ;Diabetes Care. 2016 Oct 1
• 20 citations
  Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose
  Muhammad A. Abdul-Ghani, Hussein Al Jobori, Giuseppe Daniele, John Adams, Eugenio Cersosimo, Curtis L Triplitt, Ralph A. DeFronzo> ;Diabetes. 2017 Sep 1
• Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metfor...
  Muhammad A. Abdul-Ghani, Osama Migahid, Ayman Megahed, John Adams, Curtis L Triplitt, Ralph A. DeFronzo, Mahmoud Zirie, Amin Jayyousi> ;Diabetes Care. 2017 Jun 13
• 5 citations
  Decreased basal hepatic glucose uptake in impaired fasting glucose.
  Mariam Alatrach, Christina Agyin, John Adams, Ralph A. DeFronzo, Muhammad A. Abdul-Ghani> ;Diabetologia. 2017 Mar 22
• 30 citations
  Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The ...
  Muhammad A. Abdul-Ghani, Osama Migahid, Ayman Megahed, John Adams, Curtis L Triplitt, Ralph A. DeFronzo, Mahmoud Zirie, Amin Jayyousi> ;Diabetes Care. 2017 Mar 1
• 53 citations
  Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients
  Hussein Al Jobori, Giuseppe Daniele, John Adams, Eugenio Cersosimo, Curtis L Triplitt, Ralph A. DeFronzo, Muhammad A. Abdul-Ghani> ;Diabetes, Obesity & Metabolism. 2017 Jun 1
• 129 citations
  Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results fr...
  Muhammad A. Abdul-Ghani, Curtiss Puckett, Curtis L Triplitt, David G. Maggs, John Adams, Eugenio Cersosimo, Ralph A. DeFronzo> ;Diabetes, Obesity & Metabolism. 2015 Mar 1
• 48 citations
  Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes:: A double-tracer study
  Carolina Solis-Herrera, Curtis L Triplitt, José de Jesús Garduño-García, John Adams, Ralph A. DeFronzo, Eugenio Cersosimo> ;Diabetes Care. 2013 Sep 1
• 504 citations
  Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
  John Adams, Thongchai Pratipanawatr, Rachele Berria, Elaine Wang, Ralph A. DeFronzo, M. Cameron Sullards, Lawrence J. Mandarino> ;Diabetes. 2004 Jan 1
• 80 citations
  Skeletal Muscle Insulin Resistance in Normoglycemic Subjects with a Strong Family History of Type 2 Diabetes is Associated with Decreased Insulin-Stimulated Insulin Re...
  Wilailak Pratipanawatr, Thongchai Pratipanawatr, Kenneth Cusi, Rachele Berria, John Adams, Christopher P. Jenkinson, Katsumi Maezono, Ralph A. DeFronzo, Lawrence J. Ma...> ;Diabetes. 2001 Nov 1
• Join now to see all

Journal Articles

• Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG  
  Ralph A DeFronzo, Rucha Mehta, Christina Agyin, John Adams, The Journal of Clinical Endocrinology and Metabolism